FREEMAN KEVIN D — SEC Form 4 filings
SEC reporting owner CIK 1522478. 13 Form 4 filings on record with FilingPulse; latest filed 2026-01-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-07 to 2026-01-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 10 legs across 9 filings — 47,800 shares, $125,003 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 5,500 shares @ $3.55 ($19,514) in GALECTIN THERAPEUTICS INC, filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | Director | 13 | 10 legs · 47,800 sh · $125,003 | — | 4 |
Form 4 filings — FREEMAN KEVIN D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-21 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4/A | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-12-23 | 4/A | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-12-23 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 5,500 @ $3.55 | EDGAR |
| 2025-07-18 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 5,000 @ $2.90 | EDGAR |
| 2025-01-27 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 10,000 @ $0.81 | EDGAR |
| 2024-10-17 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 1,300 @ $2.64 | EDGAR |
| 2024-10-16 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 5,000 @ $2.70 · Purchase (P): 5,000 @ $2.70 | EDGAR |
| 2024-06-20 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 2,500 @ $2.38 | EDGAR |
| 2024-04-22 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Purchase (P): 2,500 @ $2.98 | EDGAR |
| 2024-04-09 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Code (W): 2,063 @ $0 | EDGAR |
| 2024-02-07 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1522478 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →